PTC Therapeutics to Participate at Upcoming Investor Conferences

Feb 05, 2015, 16:30 ET from PTC Therapeutics, Inc.

SOUTH PLAINFIELD, N.J., Feb 5, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences:

  • 2015 Leerink Global Healthcare Conference at the Waldorf Astoria in New York on Thursday, February 12th
  • RBC 2015 Capital Markets' Global Healthcare Conference at The New York Palace Hotel in New York on Tuesday, February 24th

The company updates will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com. The presentation will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Investor Presentation and R&D Day slides are available at the same website location.

About PTC Therapeutics, Inc.
PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and in collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com.


For more information please contact:


Media:

Investors:

Jane Baj

Emily Hill

+1 (908) 912-9167

+1 (908) 912-9327

jbaj@ptcbio.com

ehill@ptcbio.com

SOURCE PTC Therapeutics, Inc.



RELATED LINKS

http://www.ptcbio.com